Marinus Pharmaceuticals, Inc. - Netong Asset Bawat Isang Bahagi MRNS
Ang pamunuan ng Marinus Pharmaceuticals (MRNS) ay kasalukuyang ino-optimize ang mga packaging line at gumagamit ng mga contract manufacturing organization para sa produksyon ng gamot. Ang book value per share ay sumasalamin sa kinalabasan ng estratehiyang ito, kung saan ang -1.21 ang kumukuha sa laki ng parameter na ito. Ang paglago ay itinutulak ng ekspansyon ng Ztalmy at mga tagumpay sa Phase 3, habang ang pagiging kompetitibo ay pinapanatili ng natatanging aksyon ng ganaxolone sa paggamot ng mga bihirang genetic seizure.
marinuspharma.com - mga analytical breakdown at pangunahing sukatan (MRNS)
- presyo at pagtataya ng pinagkasunduang presyo:
- datos sa market capitalization:
- datos sa book capitalization:
- datos sa utang at liquidity:
Ratio ng Kabuuang Utang sa Stockholders Equity Marinus Pharmaceuticals|MRNS - Pangmatagalang utang sa kapital|Panandaliang utang sa equity Marinus Pharmaceuticals, Inc.|MRNS - Mga pinagsamang obligasyon sa utang|Ratio ng utang sa book capitalization Marinus Pharmaceuticals, Inc.|MRNS - Pangmatagalang utang|Panandaliang utang ng kumpanya Marinus Pharmaceuticals
Fundamental valuation ng kumpanya:Marinus, MRNS
Sa gitna ng isang klinikal na krisis at kagyat na optimisasyon ng gastos, ang Marinus Pharmaceuticals (MRNS) ay nanganganib na humarap sa capital impairment. Ang metric na book value per share ay sumasalamin sa natitirang net assets minus liabilities, na nagpapahintulot sa mga mamumuhunan na subaybayan ang mga goodwill write-down sa pamamagitan ng price action ng chart at suriin ang aktwal na asset support ng security upang maiwasan ang isang value trap.
Pagsusuri ng mga kakumpitensya ng Marinus Pharmaceuticals
Biogen Corp (BIIB) - Netong Asset Bawat Isang Bahagi|NBIX: Stockholders Equity Bawat Bahagi|Regencell Bioscience - Netong Asset Bawat Isang Bahagi|AXSM (axsome.com) - Net Assets Bawat Bahagi|Netong Asset Bawat Isang Bahagi ACADIA Pharmaceuticals Inc. (ACAD)|Stockholders Equity Bawat Bahagi Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi Supernus Corp SUPN|Accounting Book Value Bawat Bahagi CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi AMLX|TRVI (Trevi Corp) - Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi PRAX|Accounting Book Value Bawat Bahagi anavex.com|Book Value Bawat Bahagi CBLL|Book Value Bawat Bahagi PRTA (Prothena Corporation)|Netong Asset Bawat Isang Bahagi Alector|Accounting Value ng Bahagi Annexon Biosciences Inc. ANNX|Book Value Bawat Bahagi OMER (Omeros Corp.)|NGNE: Net Assets Bawat Bahagi|Netong Asset Bawat Isang Bahagi AC Immune SA|Stockholders Equity Bawat Bahagi Voyager Therapeutics Inc|NMRA (Neumora Therapeutics Inc) - Accounting Book Value Bawat Bahagi|Book Value Bawat Bahagi SCLX|TVGN (Tevogen Bio Holdings) - Netong Asset Bawat Isang Bahagi|Net Assets Bawat Bahagi alphacognition.com ACOG|Accounting Book Value Bawat Bahagi Cognition Therapeutics|Inhibikase Therapeutics Inc - Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi Cassava|ASRT - Book Value ng Bahagi|Book Value Bawat Bahagi coyatherapeutics.com COYA|Vistagen (VTGN) - Accounting Value ng Bahagi|OVID (Ovid Therapeutics Inc) - Book Value Bawat Bahagi|Book Value Bawat Bahagi ABOS|CervoMed Inc (CRVO) - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi ATHE (alteritytherapeutics.com)|Clene - Netong Asset Bawat Isang Bahagi|Accounting Book Value Bawat Bahagi PepGen Inc PEPG|Jupiter Neurosciences Inc - Book Value Bawat Bahagi|RLMD - Book Value Bawat Bahagi|ANVS (Annovis Bio Corp) - Book Value Bawat Bahagi|Grace Therapeutics (GRCE) - Accounting Book Value Bawat Bahagi|Book Value Bawat Bahagi AIFF (Firefly Neuroscience, Inc)|Net Asset Value Bawat Bahagi ANEW Medical, Inc. (KLTO)|Accounting Book Value Bawat Bahagi NRSN|Book Value Bawat Bahagi Reviva Pharmaceuticals Holdings Inc. RVPH|Accounting Book Value Bawat Bahagi MetaVia (MTVA)|Book Price ng Bahagi NeurAxis Inc NRXS|Book Value Bawat Bahagi HSDT (Helius Medical Technologies Inc.)|PASG - Net Assets Bawat Bahagi|NEUP (bionomics.com.au) - Book Value Bawat Bahagi|Minerva Neurosciences Inc (NERV) - Accounting Book Value Bawat Bahagi|ATHA (Athira) - Book Value Bawat Bahagi|Book Value Bawat Bahagi ADXN|Netong Asset Bawat Isang Bahagi Alzamend Neuro, Inc. (ALZN)|Netong Asset Bawat Isang Bahagi CYCN (cyclerion.com)|Netong Asset Bawat Isang Bahagi PTIX|Pasithea Therapeutics Corp - Net Assets Bawat Bahagi|CRGT: Netong Asset Bawat Isang Bahagi|ATXI: Accounting Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Brainstorm Cell BCLI|CARA (caratherapeutics.com) - Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi Chromocell Therapeutics Corp. (CHRO)|Stockholders Equity Bawat Bahagi ELYM|ITCI (Intra-Cellular Therapies) - Netong Asset Bawat Isang Bahagi|Net Assets Bawat Bahagi LBPH (Longboard)|NKGN - Netong Asset Bawat Isang Bahagi|Stockholders Equity Bawat Bahagi neurobopharma.com NRBO|SAGE (Sage Therapeutics) - Book Value Bawat Bahagi|Synaptogenix Inc. (SNPX) - Net Asset Value Bawat Bahagi|TRVN: Accounting Book Value Bawat Bahagi|VIGL (Vigil Neuroscience, Inc.) - Book Value Bawat Bahagi|WENA - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi CERE